FCRX
Crescent Capital BDC, Inc.
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 26, 2026
SEC
Crescent Capital BDC, Inc. (FCRX) filed a Form 25-NSE with the NYSE to remove from listing and registration its 5.00% No
25-NSE — Impact 2/10
May 13, 2026
SEC
Crescent Capital BDC reported Q1 2026 NII of $0.42/share, down 6.7% YoY from $0.45, and a net loss of ($0.42)/share driv
8-K — Impact 7/10
Apr 1, 2026
SEC
Analysis based on filing metadata only — document content was unavailable
DEFA14A — Impact 3/10
Analyst Ratings
4Strong Buy
6Buy
4Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
25-NSE
2/10
Crescent Capital BDC, Inc. (FCRX) filed a Form 25-NSE with the NYSE to remove from listing and registration its 5.00% No
May 26, 2026
BEARISH
8-K
7/10
Crescent Capital BDC reported Q1 2026 NII of $0.42/share, down 6.7% YoY from $0.45, and a net loss of ($0.42)/share driv
May 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
NEUTRAL
25-NSE
2/10
Crescent Capital BDC, Inc. (FCRX) filed a Form 25-NSE with the NYSE to remove from listing and regis
May 26, 2026
BEARISH
8-K
7/10
Crescent Capital BDC reported Q1 2026 NII of $0.42/share, down 6.7% YoY from $0.45, and a net loss o
May 13, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 71% buy across 14 analysts — 4 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -13.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -10.1% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | -10.7% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | -2.1% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 6 | 4 | 0 | 0 | 71% | |
| May 1, 2026 | 5 | 6 | 3 | 0 | 0 | 79% | |
| Apr 1, 2026 | 5 | 6 | 3 | 0 | 0 | 79% | |
| Mar 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Feb 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Jan 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.